Beijing Tong Ren Tang Chinese Medicine Company Limited (3613) Announces EGM for Renewed Distribution Agreement with China Beijing Tong Ren Tang Group

Bulletin Express

Jan 20

Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The meeting will take place at Room 1405–1409, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong.

The EGM aims to consider and, if thought fit, approve the renewed distribution framework agreement entered into between the company and China Beijing Tong Ren Tang Group Co., Ltd. on 30 December 2025. The resolution also covers the proposed annual caps for the three years ending 31 December 2028.

According to the announcement, shareholders may attend in person or appoint proxies to vote on their behalf. Proxy forms must be submitted to the company’s Hong Kong share registrar and transfer office not less than 48 hours before the meeting. The register of members will be closed from 6 February 2026 to 11 February 2026, and all share transfer documents must be lodged by 4:30 p.m. on 5 February 2026.

As of the date of the notice, the board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited comprises Executive Directors Yan Han (Chairman), Yue Zheng (Vice Chairman), and Wang Chi; Non-executive Director Feng Li; and Independent Non-executive Directors Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1184764576"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184764576\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184764576?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-20 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184764576","market":"us","top_or_hot":-1,"title":"Beijing Tong Ren Tang Chinese Medicine Company Limited (3613) Announces EGM for Renewed Distribution Agreement with China Beijing Tong Ren Tang Group","media":"Bulletin Express","content":"<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The meeting will take place at Room 1405–1409, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong.</p>\n<p>The EGM aims to consider and, if thought fit, approve the renewed distribution framework agreement entered into between the company and China Beijing Tong Ren Tang Group Co., Ltd. on 30 December 2025. The resolution also covers the proposed annual caps for the three years ending 31 December 2028.</p>\n<p>According to the announcement, shareholders may attend in person or appoint proxies to vote on their behalf. Proxy forms must be submitted to the company’s Hong Kong share registrar and transfer office not less than 48 hours before the meeting. The register of members will be closed from 6 February 2026 to 11 February 2026, and all share transfer documents must be lodged by 4:30 p.m. on 5 February 2026.</p>\n<p>As of the date of the notice, the board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited comprises Executive Directors Yan Han (Chairman), Yue Zheng (Vice Chairman), and Wang Chi; Non-executive Director Feng Li; and Independent Non-executive Directors Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Tong Ren Tang Chinese Medicine Company Limited (3613) Announces EGM for Renewed Distribution Agreement with China Beijing Tong Ren Tang Group</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Tong Ren Tang Chinese Medicine Company Limited (3613) Announces EGM for Renewed Distribution Agreement with China Beijing Tong Ren Tang Group\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-20 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The meeting will take place at Room 1405–1409, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong.</p>\n<p>The EGM aims to consider and, if thought fit, approve the renewed distribution framework agreement entered into between the company and China Beijing Tong Ren Tang Group Co., Ltd. on 30 December 2025. The resolution also covers the proposed annual caps for the three years ending 31 December 2028.</p>\n<p>According to the announcement, shareholders may attend in person or appoint proxies to vote on their behalf. Proxy forms must be submitted to the company’s Hong Kong share registrar and transfer office not less than 48 hours before the meeting. The register of members will be closed from 6 February 2026 to 11 February 2026, and all share transfer documents must be lodged by 4:30 p.m. on 5 February 2026.</p>\n<p>As of the date of the notice, the board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited comprises Executive Directors Yan Han (Chairman), Yue Zheng (Vice Chairman), and Wang Chi; Non-executive Director Feng Li; and Independent Non-executive Directors Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03613","symbol_name":"同仁堂国药","start_time":0,"source_url":"","article_id":"1184764576","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184764576","pubTimestamp":1768903389,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03613":"同仁堂国药"},"translate_title":"北京同仁堂中药股份有限公司(3613)宣布就与中国北京同仁堂集团续签经销协议举行股东特别大会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":1},"content_text":"Beijing Tong Ren Tang Chinese Medicine Company Limited (Stock Code: 3613) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for Wednesday, 11 February 2026 at 10:00 a.m. The meeting will take place at Room 1405–1409, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong.\nThe EGM aims to consider and, if thought fit, approve the renewed distribution framework agreement entered into between the company and China Beijing Tong Ren Tang Group Co., Ltd. on 30 December 2025. The resolution also covers the proposed annual caps for the three years ending 31 December 2028.\nAccording to the announcement, shareholders may attend in person or appoint proxies to vote on their behalf. Proxy forms must be submitted to the company’s Hong Kong share registrar and transfer office not less than 48 hours before the meeting. The register of members will be closed from 6 February 2026 to 11 February 2026, and all share transfer documents must be lodged by 4:30 p.m. on 5 February 2026.\nAs of the date of the notice, the board of directors of Beijing Tong Ren Tang Chinese Medicine Company Limited comprises Executive Directors Yan Han (Chairman), Yue Zheng (Vice Chairman), and Wang Chi; Non-executive Director Feng Li; and Independent Non-executive Directors Tsang Yok Sing, Jasper, Xu Hong Xi, and Chan Ngai Chi.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}